Inhalation Drug Delivery Summit, 2021

Strategic Development, Commercialization, & Emerging Applications

December 7-8, 2021, San Diego, (Hybrid)

Meet Our 2021 Speakers

Hugh D. Smyth
Hugh D. Smyth
Professor
University of Texas at Austin
Sara Waxberg-McNew
Sara Waxberg-McNew
Chief Research Officer
Design Science Consulting
Badre Hammond
Badre Hammond
VP of Commercial Operations
Aptar CSP Technologies
George Cusatis
George Cusatis
Director, Device & Digital Health
Merck
David Cipolla
David Cipolla
VP of Research
Insmed, Inc.
Ju Du
Ju Du
Research Scientist
AstraZeneca
Donovan B. Yeates
Donovan B. Yeates
CEO
KAER Biotherapeutics
Mick Hurrey
Mick Hurrey
VP Product Development
InCarda Therapeutics
Pavan Muttil
Pavan Muttil
Assoc. Professor
University of New Mexico
Larry Brown
Larry Brown
CSO
Noveome Biotherapy
Guenther Hochhaus
Guenther Hochhaus
Professor
University of Florida
Joe Barco
Joe Barco
Senior Director of Marketing
Unchained Labs
Anselm Ebert
Anselm Ebert
Director of Business Development
H&T Presspart
Michael Eakins
Michael Eakins
President
Eakins & Associates
Vladimir Malinin
Vladimir Malinin
Executive Director of Research
Insmed, Inc.
Marco Laasckmann
Marco Laasckmann
Dir. of Inhalation Technology
Harro Höfliger
Loading Events

« All Events

Inhalation Drug Delivery Summit, 2021

December 7 December 8

Why Attend:

  • Two days of presentations, panel discussions, and networking
  • Industry experts share their knowledge and lessons learned
  • Learn strategies to overcome formulation development challenges
  • How to implement human factor studies in device design
  • Gain insight into how to bring inhalation products to market

HIGHLIGHTS OF INHALATION DRUG DELIVERY 2021

 Rapid Development of an Inhaled Antiviral Therapy Against Coronavirus

~Dr. Hugh D. Smyth, Professor, University of Texas at Austin

 Non-viral Pulmonary Delivery of RNA Via Nebulization

~Dr. Ju Du, Research Scientist, AstraZeneca

Challenges & Potential Alternative Approval Pathways for Generic Suspension-based Nasal Sprays

~Dr. Guenther Hochhaus, Professor, University of Florida

Overcoming Challenges in Bringing Inhalation Delivery Products to Market

~Dr. David Cipolla, VP of Research, Insmed, Inc.

Demystifying the Regulatory Environment for Combination Products

~George Cusatis, Director of Drug Devices and Digital Health, Merck

INHALATION DRUG DELIVERY SUMMIT, 2021 SPONSORED BY

EKG Labs
JordiLabs
Element
Smithers
UnChained Labs
Harro Hofliger
Ondrug Delivery
Drug Development

About This Year’s Inhalation Drug Delivery Summit: Health & Safety First

Driven by breakthroughs in vaccine development and emerging new therapies, the country is inching closer to a new normal. While the situation remains fluid and there is still much work to be done, we are optimistic that we will be able to meet in-person safely later this year.

We are planning Inhalation Drug Delivery Summit 2021 to be an in-person/hybrid event, enabled by the increased availability of vaccination, the expected decrease in COVID transmissibility, and our ongoing implementation of public health and safety measures. The health and safety of our attendees, sponsors and speakers remains our top priority, and we will endeavor to locate a venue that can ensure the well-being of all. Inhalation Drug Delivery 2021 will also be live-streamed–the hybrid part–so that anyone who may wish to participate virtually will have the option to do so.

Illinois USA

2810 Robeson Park Drive
Champaign, IL 61822 United States
+ Google Map
217.721.5774
View Venue Website

PharmaED Resources

217.721.5774

View Organizer Website